Most large-scale trials have had relatively short follow-up periods (typically 2 to 4 years), and the sustained efficacy of these therapies beyond this timeframe has not been fully established
Who Benefits Most (and Who Doesnt Need It Yet) Strongest Candidates 8+ weeks on GLP-1 with persistent fatigue despite optimized basics Over 40 (NAD+ naturally declines 4050% between ages 4060) Lost 20+ lbs and fatigue worsened with more loss Brain fog that coffee and labs cant explain Workout recovery tanked despite creatine and protein Probably Dont Need It Yet Less than 8 weeks on GLP-1 (still adjusting) Under 35 with mild weight loss goals Fatigue clearly tied to poor sleep, low protein, or dehydration Havent checked basic labs yet (thyroid, iron, D, B12) Energy is fine no fatigue complaint How to Try It (The Practical Guide) Start here: Oral NMN 250mg daily for 14 days
The insights from recent studies provide a deeper understanding of how GLP-1 receptor agonists can play a role in craving control
Semaglutide clinics near you in Illinois simplify the process, making weight management accessible from the beginning
It raises resting energy expenditure, so the body burns more calories even at rest
American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines